(Q38022941)

English

Exploiting synthetic lethal interactions between DNA damage signaling, checkpoint control, and p53 for targeted cancer therapy

scientific article published on January 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

27 August 2017

Exploiting synthetic lethal interactions between DNA damage signaling, checkpoint control, and p53 for targeted cancer therapy (English)

1 reference

stated in

Europe PubMed Central

27 August 2017

0 references

Sandra Morandell

1

1 reference

stated in

Europe PubMed Central

PubMed ID

22749150

retrieved

27 August 2017

Michael B Yaffe

series ordinal

2

1 reference

stated in

Europe PubMed Central

27 August 2017

1 January 2012

1 reference

stated in

Europe PubMed Central

27 August 2017

Progress in Molecular Biology and Translational Science

1 reference

stated in

Europe PubMed Central

27 August 2017

110

1 reference

stated in

Europe PubMed Central

27 August 2017

289-314

1 reference

stated in

Europe PubMed Central

27 August 2017

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1164368

Identifiers

DOI

10.1016/B978-0-12-387665-2.00011-0

1 reference

stated in

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

PubMed ID

22749150

retrieved

27 August 2017

ResearchGate publication ID

228100832

0 references

(Q38022941)

Exploiting synthetic lethal interactions between DNA damage signaling, checkpoint control, and p53 for targeted cancer therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)